Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 109 entries
Sorted by: Best Match Show Resources per page
Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Cockburn J, Kemp T, Ludman P, Kinnaird T, Johnson T, Curzen N, Robinson D, Mamas M, de Belder A, Hildick-Smith D.
PMID: 33283484
Catheter Cardiovasc Interv. 2021 Dec 01;98(7):1300-1307. doi: 10.1002/ccd.29406. Epub 2020 Dec 06.

OBJECTIVE: Octogenarians are a high-risk group presenting for percutaneous coronary intervention (PCI). We aimed to create a 30-day mortality risk model for octogenarians presenting with both acute coronary syndrome (ACS) and chronic stable angina (CSA), using comprehensive mandatory UK...

Cite
Cockburn J, Kemp T, Ludman P, et al. Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly. Catheter Cardiovasc Interv. 2020;98(7):1300-1307doi: 10.1002/ccd.29406.
Cockburn, J., Kemp, T., Ludman, P., Kinnaird, T., Johnson, T., Curzen, N., Robinson, D., Mamas, M., de Belder, A., Hildick-Smith, D. (2021). Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 98(7), 1300-1307. https://doi.org/10.1002/ccd.29406
Cockburn, James, et al. "Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly." Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions vol. 98,7 (2021): 1300-1307. doi: https://doi.org/10.1002/ccd.29406
Cockburn J, Kemp T, Ludman P, Kinnaird T, Johnson T, Curzen N, Robinson D, Mamas M, de Belder A, Hildick-Smith D. Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly. Catheter Cardiovasc Interv. 2021 Dec 01;98(7):1300-1307. doi: 10.1002/ccd.29406. Epub 2020 Dec 06. PMID: 33283484.
Copy Download .nbib Format: NLM
The pharmacokinetics of therapeutic arsenic trioxide in acute promyelocytic leukemia patients.

Leukemia & lymphoma

Ghiuzeli CM, Stýblo M, Saunders J, Calabro A, Budman D, Allen S, Devoe C, Dhingra R.
PMID: 34689693
Leuk Lymphoma. 2021 Oct 25;1-11. doi: 10.1080/10428194.2021.1978084. Epub 2021 Oct 25.

Arsenic trioxide (ATO) treats Acute Promyelocytic Leukemia (APL). ATO is converted from inorganic arsenic (iAs) to methylated (MAs) and dimethylated (DMAs) metabolites, which are excreted in the urine. Methylation of iAs is important in detoxification, as iAs exposure is...

Cite
Ghiuzeli CM, Stýblo M, Saunders J, et al. The pharmacokinetics of therapeutic arsenic trioxide in acute promyelocytic leukemia patients. Leuk Lymphoma. 2021;1-11doi: 10.1080/10428194.2021.1978084.
Ghiuzeli, C. M., Stýblo, M., Saunders, J., Calabro, A., Budman, D., Allen, S., Devoe, C., & Dhingra, R. (2021). The pharmacokinetics of therapeutic arsenic trioxide in acute promyelocytic leukemia patients. Leukemia & lymphoma, 1-11. https://doi.org/10.1080/10428194.2021.1978084
Ghiuzeli, Cristina M, et al. "The pharmacokinetics of therapeutic arsenic trioxide in acute promyelocytic leukemia patients." Leukemia & lymphoma vol. (2021): 1-11. doi: https://doi.org/10.1080/10428194.2021.1978084
Ghiuzeli CM, Stýblo M, Saunders J, Calabro A, Budman D, Allen S, Devoe C, Dhingra R. The pharmacokinetics of therapeutic arsenic trioxide in acute promyelocytic leukemia patients. Leuk Lymphoma. 2021 Oct 25;1-11. doi: 10.1080/10428194.2021.1978084. Epub 2021 Oct 25. PMID: 34689693.
Copy Download .nbib Format: NLM
Surgical legacy.

Surgery, gynecology & obstetrics

Laufman H.
PMID: 5901302
Surg Gynecol Obstet. 1966 Feb;122(2):353-4.

No abstract available.

Cite
Laufman H. Surgical legacy. Surg Gynecol Obstet. 1966;122(2):353-4
Laufman, H. (1966). Surgical legacy. Surgery, gynecology & obstetrics, 122(2), 353-4.
Laufman, H. "Surgical legacy." Surgery, gynecology & obstetrics vol. 122,2 (1966): 353-4.
Laufman H. Surgical legacy. Surg Gynecol Obstet. 1966 Feb;122(2):353-4. PMID: 5901302.
Copy Download .nbib Format: NLM
Discovery of TD-0212, an Orally Active Dual Pharmacology AT.

ACS medicinal chemistry letters

McKinnell RM, Fatheree P, Choi SK, Gendron R, Jendza K, Olson Blair B, Budman J, Hill CM, Hegde LG, Yu C, McConn D, Hegde SS, Marquess DG, Klein U.
PMID: 30655952
ACS Med Chem Lett. 2018 Dec 03;10(1):86-91. doi: 10.1021/acsmedchemlett.8b00462. eCollection 2019 Jan 10.

Dual inhibition of angiotensin-converting enzyme (ACE) and neprilysin (NEP) by drugs such as omapatrilat produces superior antihypertensive efficacy relative to ACE inhibitors but is associated with a higher risk of life-threatening angioedema due to bradykinin elevations. We hypothesized that...

Cite
McKinnell RM, Fatheree P, Choi SK, et al. Discovery of TD-0212, an Orally Active Dual Pharmacology AT. ACS Med Chem Lett. 2018;10(1):86-91doi: 10.1021/acsmedchemlett.8b00462.
McKinnell, R. M., Fatheree, P., Choi, S. K., Gendron, R., Jendza, K., Olson Blair, B., Budman, J., Hill, C. M., Hegde, L. G., Yu, C., McConn, D., Hegde, S. S., Marquess, D. G., & Klein, U. (2019). Discovery of TD-0212, an Orally Active Dual Pharmacology AT. ACS medicinal chemistry letters, 10(1), 86-91. https://doi.org/10.1021/acsmedchemlett.8b00462
McKinnell, R Murray, et al. "Discovery of TD-0212, an Orally Active Dual Pharmacology AT." ACS medicinal chemistry letters vol. 10,1 (2019): 86-91. doi: https://doi.org/10.1021/acsmedchemlett.8b00462
McKinnell RM, Fatheree P, Choi SK, Gendron R, Jendza K, Olson Blair B, Budman J, Hill CM, Hegde LG, Yu C, McConn D, Hegde SS, Marquess DG, Klein U. Discovery of TD-0212, an Orally Active Dual Pharmacology AT. ACS Med Chem Lett. 2018 Dec 03;10(1):86-91. doi: 10.1021/acsmedchemlett.8b00462. eCollection 2019 Jan 10. PMID: 30655952; PMCID: PMC6331171.
Copy Download .nbib Format: NLM
Orellanine specifically targets renal clear cell carcinoma.

Oncotarget

Buvall L, Hedman H, Khramova A, Najar D, Bergwall L, Ebefors K, Sihlbom C, Lundstam S, Herrmann A, Wallentin H, Roos E, Nilsson UA, Johansson M, Törnell J, Haraldsson B, Nyström J.
PMID: 29207627
Oncotarget. 2017 Jul 25;8(53):91085-91098. doi: 10.18632/oncotarget.19555. eCollection 2017 Oct 31.

Renal cell carcinoma (RCC), arising from the proximal tubule in the kidney, accounts for approximately 85% of kidney cancers and causes over 140,000 annual deaths worldwide. In the last decade, several new therapies have been identified for treatment of...

Cite
Buvall L, Hedman H, Khramova A, et al. Orellanine specifically targets renal clear cell carcinoma. Oncotarget. 2017;8(53):91085-91098doi: 10.18632/oncotarget.19555.
Buvall, L., Hedman, H., Khramova, A., Najar, D., Bergwall, L., Ebefors, K., Sihlbom, C., Lundstam, S., Herrmann, A., Wallentin, H., Roos, E., Nilsson, U. A., Johansson, M., Törnell, J., Haraldsson, B., & Nyström, J. (2017). Orellanine specifically targets renal clear cell carcinoma. Oncotarget, 8(53), 91085-91098. https://doi.org/10.18632/oncotarget.19555
Buvall, Lisa, et al. "Orellanine specifically targets renal clear cell carcinoma." Oncotarget vol. 8,53 (2017): 91085-91098. doi: https://doi.org/10.18632/oncotarget.19555
Buvall L, Hedman H, Khramova A, Najar D, Bergwall L, Ebefors K, Sihlbom C, Lundstam S, Herrmann A, Wallentin H, Roos E, Nilsson UA, Johansson M, Törnell J, Haraldsson B, Nyström J. Orellanine specifically targets renal clear cell carcinoma. Oncotarget. 2017 Jul 25;8(53):91085-91098. doi: 10.18632/oncotarget.19555. eCollection 2017 Oct 31. PMID: 29207627; PMCID: PMC5710908.
Copy Download .nbib Format: NLM
Clinical outcomes and costs of cardiac revascularisation in England and New York state.

Open heart

Leyva F, Qiu T, Evison F, Christoforou C, McNulty D, Ludman P, Ray D.
PMID: 29344378
Open Heart. 2018 Jan 03;5(1):e000704. doi: 10.1136/openhrt-2017-000704. eCollection 2018.

OBJECTIVES: Healthcare expenditure per-capita in the USA is higher than in England. We hypothesised that clinical outcomes after cardiac revascularisation are better in the USA. We compared costs and outcomes of patients undergoing coronary artery bypass grafting (CABG) and...

Cite
Leyva F, Qiu T, Evison F, et al. Clinical outcomes and costs of cardiac revascularisation in England and New York state. Open Heart. 2018;5(1):e000704doi: 10.1136/openhrt-2017-000704.
Leyva, F., Qiu, T., Evison, F., Christoforou, C., McNulty, D., Ludman, P., & Ray, D. (2018). Clinical outcomes and costs of cardiac revascularisation in England and New York state. Open heart, 5(1), e000704. https://doi.org/10.1136/openhrt-2017-000704
Leyva, Francisco, et al. "Clinical outcomes and costs of cardiac revascularisation in England and New York state." Open heart vol. 5,1 (2018): e000704. doi: https://doi.org/10.1136/openhrt-2017-000704
Leyva F, Qiu T, Evison F, Christoforou C, McNulty D, Ludman P, Ray D. Clinical outcomes and costs of cardiac revascularisation in England and New York state. Open Heart. 2018 Jan 03;5(1):e000704. doi: 10.1136/openhrt-2017-000704. eCollection 2018. PMID: 29344378; PMCID: PMC5761281.
Copy Download .nbib Format: NLM
Multidisciplinary exhibit design in a Science Centre: a participatory action research approach.

Educational action research

Rudman H, Bailey-Ross C, Kendal J, Mursic Z, Lloyd A, Ross B, Kendal RL.
PMID: 30363436
Educ Action Res. 2017 Aug 20;26(4):567-588. doi: 10.1080/09650792.2017.1360786. eCollection 2018.

In this paper we highlight the issues and opportunities of a participatory action research (PAR) and co-design project, currently being undertaken as engaged research between academics at Durham University and practitioners at the UK's International Centre for Life in...

Cite
Rudman H, Bailey-Ross C, Kendal J, et al. Multidisciplinary exhibit design in a Science Centre: a participatory action research approach. Educ Action Res. 2017;26(4):567-588doi: 10.1080/09650792.2017.1360786.
Rudman, H., Bailey-Ross, C., Kendal, J., Mursic, Z., Lloyd, A., Ross, B., & Kendal, R. L. (2018). Multidisciplinary exhibit design in a Science Centre: a participatory action research approach. Educational action research, 26(4), 567-588. https://doi.org/10.1080/09650792.2017.1360786
Rudman, Hannah, et al. "Multidisciplinary exhibit design in a Science Centre: a participatory action research approach." Educational action research vol. 26,4 (2018): 567-588. doi: https://doi.org/10.1080/09650792.2017.1360786
Rudman H, Bailey-Ross C, Kendal J, Mursic Z, Lloyd A, Ross B, Kendal RL. Multidisciplinary exhibit design in a Science Centre: a participatory action research approach. Educ Action Res. 2017 Aug 20;26(4):567-588. doi: 10.1080/09650792.2017.1360786. eCollection 2018. PMID: 30363436; PMCID: PMC6178092.
Copy Download .nbib Format: NLM
Do disposable pulse oximeter sensors impact infection rates? A review of the literature.

The Journal of hospital infection

Mabadeje O, Agwu A, Passaretti K, Lehman H, Asiyanbola B.
PMID: 20542591
J Hosp Infect. 2010 Sep;76(1):93-4. doi: 10.1016/j.jhin.2010.03.017. Epub 2010 Jun 09.

No abstract available.

Cite
Mabadeje O, Agwu A, Passaretti K, et al. Do disposable pulse oximeter sensors impact infection rates? A review of the literature. J Hosp Infect. 2010;76(1):93-4doi: 10.1016/j.jhin.2010.03.017.
Mabadeje, O., Agwu, A., Passaretti, K., Lehman, H., & Asiyanbola, B. (2010). Do disposable pulse oximeter sensors impact infection rates? A review of the literature. The Journal of hospital infection, 76(1), 93-4. https://doi.org/10.1016/j.jhin.2010.03.017
Mabadeje, O, et al. "Do disposable pulse oximeter sensors impact infection rates? A review of the literature." The Journal of hospital infection vol. 76,1 (2010): 93-4. doi: https://doi.org/10.1016/j.jhin.2010.03.017
Mabadeje O, Agwu A, Passaretti K, Lehman H, Asiyanbola B. Do disposable pulse oximeter sensors impact infection rates? A review of the literature. J Hosp Infect. 2010 Sep;76(1):93-4. doi: 10.1016/j.jhin.2010.03.017. Epub 2010 Jun 09. PMID: 20542591.
Copy Download .nbib Format: NLM
Postinflammatory hyperpigmentation after skin prick testing.

The World Allergy Organization journal

Ludman S, Penagos M, Brough HA, Flohr C, Fox AT.
PMID: 23268476
World Allergy Organ J. 2012 May;5(5):57-8. doi: 10.1097/WOX.0b013e3182488069. Epub 2012 May 15.

No abstract available.

Cite
Ludman S, Penagos M, Brough HA, et al. Postinflammatory hyperpigmentation after skin prick testing. World Allergy Organ J. 2012;5(5):57-8doi: 10.1097/WOX.0b013e3182488069.
Ludman, S., Penagos, M., Brough, H. A., Flohr, C., & Fox, A. T. (2012). Postinflammatory hyperpigmentation after skin prick testing. The World Allergy Organization journal, 5(5), 57-8. https://doi.org/10.1097/WOX.0b013e3182488069
Ludman, Sian, et al. "Postinflammatory hyperpigmentation after skin prick testing." The World Allergy Organization journal vol. 5,5 (2012): 57-8. doi: https://doi.org/10.1097/WOX.0b013e3182488069
Ludman S, Penagos M, Brough HA, Flohr C, Fox AT. Postinflammatory hyperpigmentation after skin prick testing. World Allergy Organ J. 2012 May;5(5):57-8. doi: 10.1097/WOX.0b013e3182488069. Epub 2012 May 15. PMID: 23268476; PMCID: PMC3488924.
Copy Download .nbib Format: NLM
WITHDRAWN: A comment on the application of statistical process control in the surgical arena.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Gutman R, Gutman H.
PMID: 21439759
Eur J Surg Oncol. 2011 Mar 24; doi: 10.1016/j.ejso.2011.02.013. Epub 2011 Mar 24.

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

Cite
Gutman R, Gutman H. WITHDRAWN: A comment on the application of statistical process control in the surgical arena. Eur J Surg Oncol. 2011;doi: 10.1016/j.ejso.2011.02.013.
Gutman, R., & Gutman, H. (2011). WITHDRAWN: A comment on the application of statistical process control in the surgical arena. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, . https://doi.org/10.1016/j.ejso.2011.02.013
Gutman, R, and Gutman, H. "WITHDRAWN: A comment on the application of statistical process control in the surgical arena." European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology vol. (2011). doi: https://doi.org/10.1016/j.ejso.2011.02.013
Gutman R, Gutman H. WITHDRAWN: A comment on the application of statistical process control in the surgical arena. Eur J Surg Oncol. 2011 Mar 24; doi: 10.1016/j.ejso.2011.02.013. Epub 2011 Mar 24. PMID: 21439759.
Copy Download .nbib Format: NLM
Occluded Mesenteric Veins: Site of Growth and Elaboration of Bacteria in Intestinal Strangulation Obstruction.

Annals of surgery

Laufman H, Nora PF.
PMID: 17859717
Ann Surg. 1962 Dec;156(6):961-4. doi: 10.1097/00000658-196212000-00015.

No abstract available.

Cite
Laufman H, Nora PF. Occluded Mesenteric Veins: Site of Growth and Elaboration of Bacteria in Intestinal Strangulation Obstruction. Ann Surg. 1962;156(6):961-4doi: 10.1097/00000658-196212000-00015.
Laufman, H., & Nora, P. F. (1962). Occluded Mesenteric Veins: Site of Growth and Elaboration of Bacteria in Intestinal Strangulation Obstruction. Annals of surgery, 156(6), 961-4. https://doi.org/10.1097/00000658-196212000-00015
Laufman, H, and Nora, P F. "Occluded Mesenteric Veins: Site of Growth and Elaboration of Bacteria in Intestinal Strangulation Obstruction." Annals of surgery vol. 156,6 (1962): 961-4. doi: https://doi.org/10.1097/00000658-196212000-00015
Laufman H, Nora PF. Occluded Mesenteric Veins: Site of Growth and Elaboration of Bacteria in Intestinal Strangulation Obstruction. Ann Surg. 1962 Dec;156(6):961-4. doi: 10.1097/00000658-196212000-00015. PMID: 17859717; PMCID: PMC1466371.
Copy Download .nbib Format: NLM
Astrophysical solutions are incompatible with the solar neutrino data.

Physical review. D, Particles and fields

Bludman S, Hata N, Langacker P.
PMID: 10017357
Phys Rev D Part Fields. 1994 Apr 01;49(7):3622-3625. doi: 10.1103/physrevd.49.3622.

No abstract available.

Cite
Bludman S, Hata N, Langacker P. Astrophysical solutions are incompatible with the solar neutrino data. Phys Rev D Part Fields. 1994;49(7):3622-3625doi: 10.1103/physrevd.49.3622.
Bludman, S., Hata, N., & Langacker, P. (1994). Astrophysical solutions are incompatible with the solar neutrino data. Physical review. D, Particles and fields, 49(7), 3622-3625. https://doi.org/10.1103/physrevd.49.3622
Bludman, et al. "Astrophysical solutions are incompatible with the solar neutrino data." Physical review. D, Particles and fields vol. 49,7 (1994): 3622-3625. doi: https://doi.org/10.1103/physrevd.49.3622
Bludman S, Hata N, Langacker P. Astrophysical solutions are incompatible with the solar neutrino data. Phys Rev D Part Fields. 1994 Apr 01;49(7):3622-3625. doi: 10.1103/physrevd.49.3622. PMID: 10017357.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 109 entries